Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25400683 | 1.00 | NPSR1 (0.54) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25398320 | 0.91 | POLB (0.51) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25398314 | 0.91 | POLB (0.51) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25399206 | 0.90 | NPSR1 (0.58) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25399210 | 0.90 | NPSR1 (0.58) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL29846698 | 0.88 | NPSR1 (0.55) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25400834 | 0.88 | CYP3A4 (0.58) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25400841 | 0.88 | CYP3A4 (0.58) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25399616 | 0.85 | NPSR1 (0.49) | NPSR1CYP2C19CYP3A4TSHRLMNA | |
| SCHEMBL25399623 | 0.85 | NPSR1 (0.49) | NPSR1CYP2C19CYP3A4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | LG CHEM, LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| EP-4242213-A1 | BORONIC ACID COMPOUND | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | NPSR1 2598/4885CYP2C19 2008/4885CYP3A4 1946/4885 |
| US-20240101579-A1 | BORONIC ACID COMPOUNDS | PSMB11, PSMB1, BACH1 | NPSR1 4263/4885CYP2C19 2880/4885CYP3A4 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.